Expression of T and B Cell Markers and Leukemia-Associated Antigens on Cell Surface of Human Lymphocytic Leukemias

  • F. Pandolfi
  • G. Luzi
  • F. Aiuti
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 20)


The cell surface of lymphoid cells is now well known to be remarkably modified in leukemic disorders both in the different pattern of expression of T and B cell markers (2,3,12,14,30) and in the appearance of leukemia-associated antigens (5,8,9,21,23,25,26). These data change after chemotherapy and become close to normal values.


Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia Lymphocytic Leukemia Acute Leukemia Chronic Myelogenous Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aiuti F., Wizgell H.: Function and distribution pattern of human T lymphocytes.I. Production of anti-T lymphocytes specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin. Exp. Immunol. 13, 171, 1973.PubMedGoogle Scholar
  2. 2.
    Aiuti F., Lacava V., Fiorilli M., Ciarla M.V.: Lymphocyte surface markers in lymphoproliferative disorders. Acta Haematol. 50, 275, 1973.PubMedCrossRefGoogle Scholar
  3. 3.
    Aiuti F., Papa G., Lacava V., Ciarla M.V., D’Amelio R., Garofalo J.: Lymphocyte membrane markers in Acute Lymphoblastic Leukaemia. Brit. J. Haematol. 27, 635, 1974.CrossRefGoogle Scholar
  4. 4.
    Aiuti F.: Techniques used for separation and characterization of T and B lymphocytes, in: Techniques of separation and characterization of human lymphocytes p.69, INSERM, Paris, 1976.Google Scholar
  5. 5.
    Baker M.A., Ramachandar K., Taub R.N.: Specificity of heteroantisera to human acute leukemia associated antigens. J. Clin. Invest. 54, 1273, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Barr R.D., Perry S.: Oncogenesis in human Acute leukemia. Blood cells 2, 319, 1976.Google Scholar
  7. 7.
    Belpomme D., Dautcher D., Durusquec E. Grandjon D., Huchet R., Pouillart P., Schwarzenberg L; Amiel J.L., Mathé G.: Marqueurs des lymphocytes B et T sur les cellules néoplasiques de 20 malades atteints de leucémie lymphöide aigue et 10 atteints de leucémie lympoide chronique. Biomedicine 20, 109, 1974.PubMedGoogle Scholar
  8. 8.
    Bias W.B., Santos G.W., Burke P.J., Mullins G.M., Humphrey R.L.: Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science 178, 304, 1972.PubMedCrossRefGoogle Scholar
  9. 9.
    Billing R., Terasaki P.I.: Human leukemia antigen. J. Nat. Cancer Inst. 53, 1635, 1974.PubMedGoogle Scholar
  10. 10.
    Billing R., Rafizadeh B., Drew I., Hartman G., Gale R., Terasaki P.: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera. J. Exp. Med. 144, 167, 1976.PubMedCrossRefGoogle Scholar
  11. 11.
    Boggs D.R.: Hemopoietic stem cell theory in relation to possible lymphoblastic conversion of chronic myeloid leukemia. Blood 44, 449, 1974.PubMedGoogle Scholar
  12. 12.
    Borella L., Sen L.: T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J. Immunol. 111, 1257, 1973.PubMedGoogle Scholar
  13. 13.
    Brouet J.C., Valensi F. Daniel M.T., Flandrin G., Preud’homme J.L., Seligmann M.: Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients. Brit. J. Haematol. 33, 319, 1976.CrossRefGoogle Scholar
  14. 14.
    Brown G., Greaves M.F., Lister T.A., Rapson N., Papamichael M.: The expression of human T and B lymphocytes cell-surface markers on leukaemic cells. Lancet ii, 753, 1974.CrossRefGoogle Scholar
  15. 15.
    Catovsky D., Galetto J., Okos., Miliani E., Galton D.A.G.: Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J. Clin. Pathol. 27, 767, 1974.PubMedCrossRefGoogle Scholar
  16. 16.
    Chess L., Levine H., Mac Dermott R.P., Schlossman S.F.: Immunological functions of isolated human lymphocyte subpopulations. VI. Further characterization of the surface Ig negative, E rosette negative (Null cell) subset. J. Immunol. 115, 1483, 1975.PubMedGoogle Scholar
  17. 17.
    Chin A.H. Saiki J.H., Trujillo J.M., Williams R.C.: Peripheral blood T and B lymphocytes in patients with lymphoma and acute leukemia. Clin. Immunol. Immunopathol. 1, 499, 1973.PubMedCrossRefGoogle Scholar
  18. 18.
    Fu M.S., Winchester R.J., Kunkel H.G.: The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J. Exp. Med. 142, 1334, 1975.PubMedCrossRefGoogle Scholar
  19. 19.
    Greaves M.F., Brown G., Rapson N.T., Lister T.A.: Antisera to acute lymphoblastic leukemia cells. Clin. Immunol. Immunopathol. 4, 67, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Haltermann R.H., Leventhal B.G., Mann D.L.: An acute leukemia antigen: correlation with clinical status. N. Engl. J. Med. 287, 1272, 1972.CrossRefGoogle Scholar
  21. 21.
    Harris R., Leukemia antigens and immunity in man. Nature, Lond. 241, 95, 1973.CrossRefGoogle Scholar
  22. 22.
    Kersey J., Nesbit M., Hallgren H., Sabad A., Yunis E., Gajl-Peczalska K.: Evidence for origin of certain childhood acute lymphoblastic leukemias and lymphomas in thymus-derived lymphocytes. Cancer 36, 1348, 1975.PubMedCrossRefGoogle Scholar
  23. 23.
    Mann D.L., Rogentine G.N., Halterman R., Leventhal B.: Detection of an antigen associated with acute leukemia. Science 174, 1136, 1971.PubMedCrossRefGoogle Scholar
  24. 24.
    McCaffrey R., Harrison T.A., Parkman R., Baltimore D.: Terminal deoxynucleo-tidyl transferase activity in human leukemic cells and in normal human thymocytes. N. Engl. J. Med. 292, 775, 1975.PubMedCrossRefGoogle Scholar
  25. 25.
    Metzgar R.S., Mohanakumar T., Miller D.S.: Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science 178, 986, 1972.PubMedCrossRefGoogle Scholar
  26. 26.
    Mohanakumar T., Metzgar R.S., Miller D.S.: Human leukemia cell antigens: serologic characterization with xenoantisera. J. Nat. Cancer Inst. 52, 1453, 1974.Google Scholar
  27. 27.
    Moore M.A.S., Spitzer N., Williams N., Metcalf D., Buckley J.: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood 44, 1, 1974.PubMedGoogle Scholar
  28. 28.
    Pandolfi F., Luzi G., Tozzi M.C., Aiuti F.: Preparation, purification and in vitro properties of a serum against human lymphoblastic leukemia-associated antigens. Acta Haematol. in press.Google Scholar
  29. 29.
    Schlossman S.F., Chess L., Humphreys R.E., Strominger J.L.: Distribution of la-like molecules on the surface of normal and leukemic human cells. Proc. Nat.Acad.Sci.USA 73, 1288, 1976.PubMedCrossRefGoogle Scholar
  30. 30.
    Seligman M., Preud’homme J.L., Brouet J.C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant. Rev. 16, 85, 1973.Google Scholar
  31. 31.
    Sen L. Borella L.: Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N. Eng. J. Med. 292, 828, 1975.CrossRefGoogle Scholar
  32. 32.
    WHO Special Technical Report: Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Scand. J. Immunol. 3, 521, 1974.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1977

Authors and Affiliations

  • F. Pandolfi
    • 1
  • G. Luzi
    • 1
  • F. Aiuti
    • 1
  1. 1.Department of Clinical Medicine IIIUniversity of RomeItaly

Personalised recommendations